Abstract | PURPOSE:
PCK3145 is an anti-metastatic synthetic peptide with promising therapeutic efficacy against hormone-refractory prostate cancer. The characterization of the PCK3145 peptide cell surface binding/internalization mechanisms and of the receptors involved remained to be explored. RESULTS: CONCLUSIONS:
|
Authors | Borhane Annabi, Jean-Christophe Currie, Mounia Bouzeghrane, Hélène Dulude, Luc Daigneault, Seema Garde, Shafaat A Rabbani, Chandra Panchal, Jinzi J Wu, Richard Béliveau |
Journal | Biochemical and biophysical research communications
(Biochem Biophys Res Commun)
Vol. 346
Issue 1
Pg. 358-66
(Jul 21 2006)
ISSN: 0006-291X [Print] United States |
PMID | 16759641
(Publication Type: Journal Article)
|
Chemical References |
- Collagen Type I
- Oligopeptides
- Peptide Fragments
- Prostatic Secretory Proteins
- Protein Precursors
- Receptors, Cell Surface
- Receptors, Laminin
- tigapotide
- arginyl-glycyl-aspartic acid
- Catechin
- epigallocatechin gallate
- Matrix Metalloproteinase 9
|
Topics |
- Catechin
(analogs & derivatives, pharmacology)
- Cell Communication
- Cell Line, Tumor
- Collagen Type I
(pharmacology)
- Drug Synergism
- Humans
- Kinetics
- Matrix Metalloproteinase 9
(metabolism)
- Neoplasm Metastasis
(drug therapy)
- Oligopeptides
(pharmacology)
- Peptide Fragments
(metabolism)
- Prostatic Secretory Proteins
(metabolism)
- Protein Precursors
(metabolism)
- Receptors, Cell Surface
(metabolism)
- Receptors, Laminin
(metabolism)
|